Development and validation of a severity scale for leprosy type 1 reactions

PLoS Neglected Tropical Diseases

Volumn 2, Issue 12, 2008, Pages

  Walker, Stephen L ^a   Nicholls, Peter G ^b   Butlin, C Ruth ^c   Nery, Jose Augusto C ^d   Roy, Hemanto K ^c   Rangel, Emanuel ^d   Sales, Anna M ^d   Lockwood, Diana N J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c DBLM Hospital   (Bangladesh)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BANGLADESH; BRAZIL; CHILD; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DISEASE SEVERITY; FACE VALIDITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERVENTION STUDY; LEPROSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OBSERVATIONAL STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCHOOL CHILD; SCORING SYSTEM; VALIDATION PROCESS; CLASSIFICATION; HOSPITALIZATION; MEDIAN NERVE; MIDDLE AGED; NERVOUS SYSTEM; PATHOPHYSIOLOGY; QUESTIONNAIRE; ULNAR NERVE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BANGLADESH; BRAZIL; CHILD; FEMALE; HUMANS; LEPROSY; MALE; MEDIAN NERVE; MIDDLE AGED; NERVOUS SYSTEM; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; ULNAR NERVE;

EID: 65549101679     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000351     Document Type: Article

References (23)

1. (2008) Global leprosy situation, beginning of 2008. Wkly Epidemiol Rec 83: 293-300.
2. Ridley DS, Jopling WH (1966) Classification of Leprosy according to immunity. Int J Lepr Other Mycobact Dis 34: 255-273.
3. Modlin RL (1994) Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 102: 828-832.
4. van Brakel WH, Nicholls PG, Das L, Barkataki P, Suneetha SK, et al. (2005) The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. Lepr Rev 76: 14-34.
5. Ranque B, Nguyen VT, Vu HT, Nguyen TH, Nguyen NB, et al. (2007) Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy. Clin Infect Dis 44: 33-40.
6. van Brakel WH, Khawas IB (1996) Nerve function impairment in leprosy: an epidemiological and clinical study-Part 2: Results of steroid treatment. Lepr Rev 67: 104-118.
7. Van Brakel WH, Saunderson P, Shetty V, Brandsma JW, Post E, et al. (2007) International workshop on neuropathology in leprosy-consensus report. Lepr Rev 78: 416-433.
8. Van Brakel WH, Nicholls PG, Lockwood DN, Rao PS, Smith WC (2007) A scale to assess the severity of leprosy reactions. Lepr Rev 78: 161-164.
9. Marlowe SN, Hawksworth RA, Butlin CR, Nicholls PG, Lockwood DN (2004) Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy Type 1 reactions in Nepal. Trans R Soc Trop Med Hyg 98: 602-609.
10. Naafs B, Dagne T (1977) Sensory testing: a sensitive method in the follow-up of nerve involvement. Int J Lepr Other Mycobact Dis 45: 364-368.
11. Naafs B, van Drogenbroeck JBA (1977) Decompression des nevrites reaction-nelles dans la lepre: justification physiopathologique et methodes objectives pour en aprecier les resultats. Med Trop 37: 763-770.
12. Brain (2000) Aids to the examination of the peripheral nervous system. Philadelphia: W.B. Saunders.
13. Streiner DL, Norman GR (2003) Health Measurement Scales:A practical guide to their development and use. Oxford: Oxford University Press.
14. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
15. Bland JM, Altman DG (1995) Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346: 1085-1087.
16. Cronbach LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52: 281-302.
17. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, et al. (2000) Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. Br J Psychiatry 176: 249-252.
18. Anderson AM, Croft RP (1999) Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh. Lepr Rev 70: 305-313.
19. Van Brakel WH, Nicholls PG, Das L, Barkataki P, Maddali P, et al. (2005) The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline. Lepr Rev 76: 277-295.
20. Roberts AE, Nicholls PG, Maddali P, Van Brakel WH (2007) Ensuring intertester reliability of voluntary muscle and monofilament sensory testing in the INFIR Cohort Study. Lepr Rev 78: 122-130.
21. van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, et al. (2008) Early Diagnosis of Neuropathy in Leprosy-Comparing Diagnostic Tests in a Large Prospective Study (the INFIR Cohort Study). PLoS Negl Trop Dis 2: e212. doi:10.1371/journal.pntd.0000212.
22. Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL (2005) Validation of a new coma scale: The FOUR score. Ann Neurol 58: 585-593.
23. Richardus JH, Withington SG, Anderson AM, Croft RP, Nicholls PG, et al. (2003) Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3). Lepr Rev 74: 311-318.